Commercial Evidence Drives Industry Forward with Agentic AI in Veeva Vault CRM

Regeneron Pharmaceuticals has committed to using Veeva Systems' Vault CRM globally. The company plans to use the CRM to generate Commercial Evidence from AI-powered field engagement, aiming to uncover barriers to treatment adoption. Ryan Steinberger from Regeneron said the move will provide their commercial teams with a more connected platform for efficient decision-making. Read more: https://lnkd.in/gh86DUGe 📰 Subscribe to the Life AI Weekly Newsletter: https://lnkd.in/eC5-u69w #ai #artificialintelligence #ainews #biotech #healthcareai

When data moves at the speed of your field teams, they spend less time managing information and more time supporting customers. Hear Veeva OpenData leaders Todd Bellemare and Ryan Sowers discuss how pairing AI agents with human expertise keeps customer reference data updated, accurate, and reliable. Watch the full interview here: https://lnkd.in/easwP2p5 Highlights: - Large health systems are automatically mapped to reflect how they actually operate. - Data change requests are processed with 95% accuracy in minutes, allowing reps to submit changes on the go and immediately see new data in CRM. - Agentic data curation replaces manual review, combining speed and accuracy to keep data clean effortlessly. #lifesciences #pharmaceuticals #dataquality

Are your clinical trials slowed down by scattered data, manual processes, and disjointed systems? In today’s fast-paced healthcare and pharmaceutical landscape, inefficiency isn’t just costly — it can delay innovation and impact patient outcomes. That’s where Cerionix CTMS comes in. Designed to unify your trial operations, Cerionix empowers research organizations to move faster, smarter, and with greater confidence. ✨ With Cerionix, you can: Streamline trial management with a centralized, intuitive platform Integrate seamlessly with ERP & CRM systems for unified workflows Gain real-time insights through smart reporting & analytics Empower researchers and volunteers with mobile-friendly apps Customize solutions to fit the unique needs of medical and pharmaceutical organizations 🚀 Transform complexity into clarity. Turn operational chaos into efficiency. Unlock the full potential of your clinical research with Cerionix. 📞 +201555733952 🌐 https://cerionix.com/ Craftcrew — Smart Advertising Powered by AI #Craftcrew #Cerionix #CTMS #ClinicalTrials #HealthcareAutomation #ERP #CRM #AI

EVERSANA expands its AI commercialization platform across medical affairs, market research and pharmaceutical commercial operations Read the Latest Full News – https://lnkd.in/dNqNASb5 #MarTechEdge #MarTech #EVERSANA #AIinMarketing #EnterpriseAI #AgenticAI #PharmaTech #LifeSciences #MarketingAutomation #MedicalAffairs #Commercialization #AITransformation

Eli Lilly's 48% revenue surge from GLP-1 blockbusters has created an unexpected challenge: how do you manage commercial operations when your drugs scale faster than your infrastructure? The answer: AI agents. Lilly just committed to deploying Veeva's "agentic commercial" AI framework globally—a strategic bet that enterprise AI platforms are now mission-critical for pharma field operations. As Mounjaro and Zepbound reach multi-billion-dollar milestones, traditional CRM systems can't keep pace with the complexity of coordinating rep routing, content delivery, and engagement at this scale. This signals a broader shift in life sciences: commercial success increasingly depends on AI infrastructure, not just drug efficacy. When your therapy goes from promising to blockbuster overnight, your operational backbone needs to scale just as fast. Veeva's AI agents are designed to handle exactly that—automating the orchestration layer that human teams simply can't manage at global scale. For pharma companies racing to commercialize the next generation of breakthrough therapies, the message is clear: your AI infrastructure may be just as important as your clinical pipeline. How do you think AI agents will reshape pharmaceutical commercial operations over the next 3 years? #HealthAI #PharmaInnovation #AIinHealthcare #DigitalHealth #LifeSciences Read more: https://lnkd.in/eqp5wHMm

Commercial teams shouldn't have to jump between dashboards to answer a simple business question. In this clip, see how AI brings together market intelligence, clinical research, and competitive insights in a single workflow, helping pharma teams understand competitor performance, identify differentiation, and make faster, more informed decisions. 🎥 Watch the on demand recording here: https://lnkd.in/gBYgSS73 #Pharma #EnterpriseAI #AgenticAI #SnapLogic

"The pharmaceutical industry has reached an inflection point," said Mark Thierer, Chief Executive Officer, EVERSANA. "Organizations are moving beyond isolated AI pilots and looking for practical ways to scale AI across commercialization. We're helping clients take meaningful steps toward a more connected, efficient and AI-enabled operating model that complements human expertise while maintaining the governance and compliance our industry demands." #EVERSANA #AIHealthcare #LifeSciences #PharmaTech #AIPlatform #HealthcareAI #DigitalHealth #Commercialization #PharmaInnovation #ArtificialIntelligence https://lnkd.in/dm2ne9K7

🚀 How Tier 1 Pharma Solves the $100M "Launch Bottleneck" with Agentic AI Every Commercial Leader in Life Sciences knows the pain: 🎯 You have a groundbreaking new therapy ready for market, but your Go-To-Market (GTM) rollout is crawling. ❓ The biggest friction point >> MLR (Medical, Legal, Regulatory) compliance. In a highly regulated world, marketing materials, doctor detailing aids, and sales emails cannot simply be "AI-generated" and sent. A single unapproved claim or missing safety disclosure can lead to millions in regulatory fines, brand damage, or worse. But what if your compliance gates could operate at digital speed without losing human oversight? The answer lies in combining two complementary open-source standards: Model Context Protocol (MCP) and the Agent-to-Agent (A2A) Protocol. Here is how this hybrid architecture transforms a pharma drug launch: 💡 The Vertical Layer MCP (Agent-to-Tool) Instead of letting an AI hallucinate medical claims, we deploy specialised MCP Servers. These act as secure, standardised connectors ("USB-C for AI") to our verified medical libraries, FDA-approved product labels, and clinical trial databases. The GTM agent must fetch real-time, pre-vetted data to build any commercial detail aid. 🔄 The Horizontal Layer A2A (Agent-to-Agent) A drug launch is a team sport. Under the A2A protocol, independent software agents collaborate securely across different systems: > Outreach Agents drafts localised emails for Healthcare Professionals > It automatically initiates an A2A task with the MLR Auditor Agent > The MLR Agent audits the draft against the approved claims database. 🛡️ Automated Guardrails & Human-in-the-Loop If the MLR Agent flags a missing safety warning, it transitions the A2A task to an input-required state. It doesn't fail; instead, it triggers an out-of-band notification to the Human Compliance Officer, who can adjust the text or approve with one click. 📈 The Immutable Audit Trail Once approved, the task shifts to completed. Every single step, which tool was called, what clinical claim was checked, and who approved it is logged in an immutable task history. This provides a pristine, audit-ready paper trail for FDA compliance. 📑 The Business Impact By shifting from siloed, manual workflows to a governed, multi-agent mesh, Tier 1 pharma teams can achieve 30% to 40% reductions in commercial launch cycles while enforcing a strict zero-trust security posture. The future of enterprise AI isn't a single, all-knowing chatbot. It is a highly specialized, governed network of collaborative agents that know their boundaries. #LifeSciences #PharmaGTM #AgenticAI #ModelContextProtocol #A2A #HealthcareCompliance #DigitalHealth

💊 Healthcare Data Is Everywhere. The Challenge Is Making Sense of It. Healthcare and pharma businesses deal with huge amounts of publicly available data — drug prices, clinical trials, FDA updates, physician directories, medical devices, formularies, and research publications. But collecting and monitoring all of this manually is difficult. With healthcare & pharma data scraping, businesses can turn scattered public information into structured intelligence for: 💊 Drug price monitoring 🧬 Clinical trial tracking 📋 FDA & regulatory monitoring 🏥 Physician & provider data 🔬 Medical device intelligence 🏦 Insurance & formulary analysis 📰 Medical research monitoring At MyDataScraper, we build data pipelines that collect, clean, normalize, and deliver healthcare market intelligence for research and business analysis. The goal is simple: Less manual research. More actionable data. 🌐 Explore: https://mydatascraper.com/ We focus on publicly available healthcare information and do not collect or process Protected Health Information (PHI). #HealthcareData #Pharma #DataScraping #HealthcareAnalytics #ClinicalTrials #DrugPricing #MarketResearch #DataIntelligence #WebScraping #MyDataScraper

Team Expertise Overview Our team combines 30+ years of regulatory, scientific, and digital transformation experience across the UK, EU, and MENA regions, shaped within leading global pharma companies, MHRA, consumer healthcare organisations, and digital consultancies. This breadth gives us a uniquely practical, authority‑aligned, and industry‑savvy perspective. 🌍 Regulatory Affairs Excellence We bring deep hands-on expertise across: - MHRA, EMA and MENA regulatory pathways - MAAs, CTAs, PIPs, Scientific Advice - Variations, renewals, post‑approval lifecycle management - Orphan, rare disease & early access programmes (ODD, EAMS, Compassionate Use) - Product Information (SmPC, PIL, CCDS, labelling) - Promotional, non‑promotional & aRMMs review - Windsor Framework & post‑Brexit requirements - Innovative, biologic, ATMP, oncology, virology, sterile, injectables & consumer health portfolios 🏢 Experience Across Leading Organisations Our team has delivered regulatory strategy and execution within: Gilead, AstraZeneca, Pfizer, MSD, Alexion, Teva, GSK Consumer Healthcare, MHRA, Infosys. 💡 Digital Transformation & Regulatory Technology We pair regulatory expertise with strong digital capability: - Veeva Vault RIM - CRM Dynamics, PROTON - SQL, Power BI, Tableau - SDLC, process modelling - Digital Twin architecture - AI/GenAI workflow optimisation 🤝 Cross‑Functional & Strategic Leadership We’ve represented Regulatory Affairs across global project teams, clinical/CMC/medical/safety programmes, supply chain and commercial initiatives, plus organisational engagement and D&I groups. ✅ What This Means for You We support: - Early development regulatory strategy - Clinical trial submissions & maintenance - Pre‑MAA readiness - EU/UK/MENA marketing authorisation pathways - Post‑approval lifecycle management - Labelling & compliance - Regulatory intelligence & risk mitigation - Digital transformation of regulatory processes A team that blends regulatory depth, strategic insight, and digital innovation-ready to support scientific, operational, and strategic challenges with precision and real‑world expertise.